Nanjing, China

Haolong Zhang

This inventor holds 1 USPTO granted patent. Top assignee: Allgenesis Biotherapeutics Inc.. Active years: 2021.


% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2021

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Haolong Zhang: Innovator in Pharmaceutical Formulations

Introduction

Haolong Zhang is a prominent inventor based in Nanjing, China. He has made significant contributions to the field of pharmaceutical formulations, particularly in the treatment of angiogenic eye diseases. His innovative work has led to the development of unique crystalline forms that enhance the efficacy of therapeutic agents.

Latest Patents

Haolong Zhang holds 1 patent for his invention titled "Crystalline forms of 3-Z-[1-(4-(N-((4-methyl-piperazin-1-yl)-methylcarbonyl)-N-methyl-amino)-phenylamino)-1-phenyl-methylene]-6-methoxycarbonyl-2-indolinone." This patent includes the crystalline forms of the free base and outlines preparation methods. Additionally, it discusses pharmaceutical formulations containing these crystalline forms and their applications in treating various diseases, particularly those affecting the eyes.

Career Highlights

Zhang's career is marked by his dedication to advancing pharmaceutical science. His work at Allgenesis Biotherapeutics Inc. has positioned him as a key player in the development of innovative treatments. His research focuses on improving drug formulations to enhance patient outcomes.

Collaborations

Throughout his career, Haolong Zhang has collaborated with notable colleagues, including Fei Liu and Cuixia Zhang. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Haolong Zhang's contributions to pharmaceutical formulations demonstrate his commitment to improving healthcare through innovation. His work continues to impact the treatment of diseases, showcasing the importance of research and development in the medical field.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…